Defensin BmKDfsin3

General Information


DRACP ID  DRACP04377

Peptide Name   Defensin BmKDfsin3

Sequence  GFGCPFNQGKCHRHCRSIRRRGGYCDGFLKQRCVCYRK

Sequence Length  38

UniProt ID  Not available

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C190H299N69O47S6

Absent amino acids  AEMTW

Common amino acids  R

Mass  515440

Pl  10.34

Basic residues  12

Acidic residues  1

Hydrophobic residues  6

Net charge  11

Boman Index  -12439

Hydrophobicity  -92.37

Aliphatic Index  28.16

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  3355

Absorbance 280nm  90.68

Polar residues  16

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31963532

Title  Inhibitory Activity of a Scorpion Defensin BmKDfsin3 against Hepatitis C Virus

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19218

DRACP is developed by Dr.Zheng's team.